Amalgamated Financial’s Praxis Precision Medicines PRAX Stock Holding History

Amalgamated Financial’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$42K	Buy	+276	New	+$56.7K	﹤0.01%	2506

Other funds holding PRAX

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VVA

Vida Ventures Advisors Boston, Massachusetts $29.4M AUM 93.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Amalgamated Financial's PRAX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Praxis Precision Medicines (PRAX) in Q1 2022: 276 shares worth $42K. The stake represents ﹤0.01% of the portfolio and ranks #2506 among its holdings.

103 funds tracked by Wall St. Rank hold PRAX as of Q1 2022.

Amalgamated Financial held 276 shares of Praxis Precision Medicines worth $42K as of Q1 2022.
Praxis Precision Medicines was a new Amalgamated Financial position in Q1 2022.
Praxis Precision Medicines made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2506 holding.
103 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.